Institutional & Family Asset Management’s Cytokinetics CYTK Stock Holding History

Institutional & Family Asset Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7	Closed	-$491	–	757
2024 Q1	$491	Hold	7	–	–	﹤0.01%	692
2023 Q4	$584	Sell	7 -9	-56%	-$326	﹤0.01%	663
2023 Q3	$471	Hold	16	–	–	﹤0.01%	669
2023 Q2	$522	Hold	16	–	–	﹤0.01%	679
2023 Q1	$563	Hold	16	–	–	﹤0.01%	665
2022 Q4	$733	Buy	16 +3	+23%	+$129	﹤0.01%	630
2022 Q3	$1K	Hold	13	–	–	﹤0.01%	623
2022 Q2	$1K	Hold	13	–	–	﹤0.01%	642
2022 Q1	$0	Sell	13 -87	-87%	-$3.09K	﹤0.01%	788
2021 Q4	$5K	Buy	+100	New	+$3.86K	﹤0.01%	557

Other funds holding CYTK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Institutional & Family Asset Management's CYTK Position: Q2 2024 in Review

Institutional & Family Asset Management sold out of Cytokinetics (CYTK) in Q2 2024, closing a stake of 7 shares — an estimated $491 sold.

Institutional & Family Asset Management first reported a position in CYTK in Q4 2021 and held it in 10 quarters. The position peaked at $5K in Q4 2021. 343 funds tracked by Wall St. Rank hold CYTK as of Q2 2024.

Institutional & Family Asset Management reported no remaining Cytokinetics position as of Q2 2024 after selling out during the quarter.
Institutional & Family Asset Management sold 7 Cytokinetics shares in Q2 2024, an estimated $491.
Institutional & Family Asset Management first reported a position in Cytokinetics in Q4 2021 and held it in 10 quarters.
Institutional & Family Asset Management's Cytokinetics position peaked at $5K in Q4 2021.
343 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2024.

Based on Institutional & Family Asset Management's 13F filing for Q2 2024, filed 5 Jul 2024.